ADHD Trial, Recruiting NCT06902649 Sponsor: Karolinska Institutet Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06902649
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Families with children aged 8 to 16 years who have trouble controlling anger, or who show defiant or aggressive behaviour, where the child meets a specific number of recognised diagnostic markers for either Oppositional Defiant Disorder (at least 3 markers) or Conduct Disorder involving aggression (at least 2 markers).
  • Any medication the child is currently taking can stay the same during the trial — no changes are required.
  • Parents or caregivers who are able to read and engage with written materials in Swedish.

Who may not be able to join:

  • Families where the child is younger than 8 years old or has already turned 17, or where the child does not show the defiant or aggressive behaviours described in the first criteria above.
  • Children who have severe depression, suicidal behaviour, bipolar disorder, psychosis, an eating disorder, severe autism (classified as level 2 or 3), a diagnosed intellectual disability, or ongoing involvement in criminal behaviour that a clinician judges would need a different type of support than what this trial offers.
  • Children or adolescents who are already receiving another psychological treatment for the same difficulties, or whom a clinician considers in need of a different type of intervention.
  • Parents or children who have epilepsy or migraines.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pia Enebrink, PhD, Karolinska Institutet

Phone: +46852487738

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 April 2025
Est. completion
31 August 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Parent: Mean change from baseline in behavior problems on parent-ratings of the Disruptive Behavior Disorder scale (oppositional defiant disorder subscale).; Parent: Mean change from baseline in oppositional defiant disorder and conduct disorder criteria; Child/youth: Mean change from baseline in child-ratings of anger on the Anger Expression Scale for children

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov